RESPIRATORY SAFETY OF LEMBOREXANT IN ADULT AND ELDERLY SUBJECTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY

被引：0
|
作者：
Moline, M. [1 ]
Cheng, J. Y. [1 ]
Lorch, D. [2 ]
Hall, N. [1 ]
Shah, D. [1 ]
机构：
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Teradan Clin Trials LLC, Brandon, FL USA
来源：
SLEEP MEDICINE | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S135 / S136
页数：2
相关论文
共 50 条
  • [1] A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea
    Cheng, Jocelyn Y.
    Lorch, Daniel
    Lowe, Alan D.
    Uchimura, Naohisa
    Hall, Nancy
    Shah, Dhara
    Moline, Margaret
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2024, 20 (01): : 57 - 65
  • [2] Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double-blind, placebo-controlled, crossover study
    Cheng, Jocelyn Y.
    Filippov, Gleb
    Moline, Margaret
    Zammit, Gary K.
    Bsharat, Mohammad
    Hall, Nancy
    JOURNAL OF SLEEP RESEARCH, 2020, 29 (04)
  • [3] Respiratory Safety of Lemborexant in Adult and Elderly Subjects With Moderate to Severe Obstructive Sleep Apnea
    Moline, Margaret
    Cheng, Jocelyn Y.
    Lorch, Daniel
    Hall, Nancy
    Shah, Dhara
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 388 - 388
  • [4] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Cheng, Jocelyn Y.
    Moline, Margaret
    Zammit, Gary K.
    Filippov, Gleb
    Bsharat, Mohammad
    Hall, Nancy
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 449 - 457
  • [5] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Jocelyn Y. Cheng
    Margaret Moline
    Gary K. Zammit
    Gleb Filippov
    Mohammad Bsharat
    Nancy Hall
    Clinical Drug Investigation, 2021, 41 : 449 - 457
  • [6] A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea
    Roizenblatt, Suely
    Guilleminault, Christian
    Poyares, Dalva
    Cintra, Fatima
    Kauati, Adriana
    Tufik, Sergio
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (16) : 1763 - 1767
  • [7] RESPIRATORY SAFETY OF LEMBOREXANT IN ADULT AND ELDERLY SUBJECTS WITH MILD OBSTRUCTIVE SLEEP APNEA
    Cheng, Jocelyn
    Moline, Margaret
    Filippov, Gleb
    Murphy, Patricia
    Bsharat, Mohammad
    Hall, Nancy
    SLEEP, 2019, 42
  • [8] Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial
    Berger, Mathieu
    Solelhac, Geoffroy
    Marchi, Nicola A.
    Dussez, Romane
    Bradley, Brian
    Lecciso, Gianpaolo
    Heiniger, Gregory
    Bayon, Virginie
    van den Broecke, Sandra
    Haba-Rubio, Jose
    Siclari, Francesca
    Heinzer, Raphael
    SLEEP, 2023, 46 (07)
  • [9] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
    Williams, S. P.
    Colice, G.
    Mcardle, J. R.
    Lankford, A.
    Kajdasz, D. K.
    Reed, C. R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A54 - A54
  • [10] Montelukast for Children With Obstructive Sleep Apnea: A Double-blind, Placebo-Controlled Study
    Goldbart, Aviv D.
    Greenberg-Dotan, Sari
    Tal, Asher
    PEDIATRICS, 2012, 130 (03) : E575 - E580
12345